Furthermore, IL-17A was shown to promote the migration and invasion of cancer cells by up-regulating the expression of MMP-9 and down-regulating the expression of the tissue inhibitor of metalloproteinase 2 (TIMP2)—a natural inhibitor of MMPs—via the p38/NF-kB signaling pathway [36, 39]. Here, IL17A is linked to cancer.